Results 91 to 100 of about 59,572 (271)

A COMPARISON OF EFFICACY AND SAFETY OF CLOZAPINE AND SULPIRIDE IN TREATMENT-RESISTANT SCHIZOPHRENIA

Psychiatry and Clinical Psychopharmacology, 2021
Object: In this study, a comparison of efficacy and tolerability of clozapine and sulpiride on treatment-resistant-schizophrenia was aimed. Method: Thirty-six in-patients with treatment-resistant schizophrenia, diagnosed according to DSM-IV diagnostic
Hasan Herken, Nazmiye Kaya, Lütfullah Beşiroğlu, Hüdaverdi Derman, İshak Özkan   +4 more
doaj  

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul Rochefort, Thibault Mura, Felix Sergent   +7 more
wiley   +1 more source

Combined use of antipsychotics and electroconvulsive therapy in theurapetically resistant schizophrenia

Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, 2018
The article provides an overview of data in the literature devoted to the combined use of electroconvulsive therapy (ECT) and antipsychotics in treatment of resistant schizophrenia. ECT with anesthesia and muscle relaxants is a fairly safe method.
S. V. Sizov, Y. B. Barylnik
doaj  

Common and unique white matter fractional anisotropy patterns in patients with schizophrenia with medication-resistant auditory verbal hallucinations: a retrospective tract-based spatial statistics study

Schizophrenia
Auditory verbal hallucinations (AVHs) are experienced by the majority of patients with schizophrenia and are often resistant to treatment with antipsychotic agents. White matter (WM) tract abnormalities are associated with AVH treatment efficacy. Using a
Chuanjun Zhuo, Chao Li, Xiaoyan Ma, Ranli Li, Ximing Chen, Yachen Li, Qiuyu Zhang, Lei Yang, Lina Wang   +8 more
doaj   +1 more source

Management of Treatment-Resistant Schizophrenia

, 2017
The most common method of pharmacotherapy for patients with schizophrenia includes the use of antipsychotic medications. This group of medications can be subdivided into typical and atypical antipsychotics, or first and second-generation antipsychotics ...
Choudhari, Justin
core  

Effect of psychosocial interventions on social functioning in depression and schizophrenia: meta-analysis. [PDF]

, 2013
BACKGROUND: Psychosocial interventions may contribute to reducing the burden of mental disorders in low- and middle-income (LAMI) countries by improving social functioning, but the evidence has not been systematically reviewed.
Li, Henry Lishi, Patel, Vikram, Cooper, Sara, De Silva, Mary J, Lund, Crick   +4 more
core   +1 more source

The CIPP-TRS Corpus: Corpus Construction and Preliminary Analyses

LingBaW
Schizophrenia, a neurodevelopmental disorder, significantly affects cognitive and linguistic functions, often resulting in disorganized speech, reduced syntactic complexity, and impaired discourse cohesion.
Laura Tagliaferro, Ludovica Fiorentino, Raffaele Guarasci, Luigi Franzese, Viviana Maria Saia, Giancarlo Spennato, Felice Iasevoli, Roberto Vitelli, Andrea de Bartolomeis, Francesca M. Dovetto   +9 more
doaj   +1 more source

Descriptive statistics of treatment resistant schizophrenia predictors.

, 2022
Descriptive statistics of treatment resistant schizophrenia predictors.
Megan Pritchard (228870), Isobel Ridler (12155761), Deborah Agbedjro (9951097), Emma Francis (7955696), Anna Morris (8733180), Richard D. Hayes (7910873), Daniel Stahl (259424), Giouliana Kadra-Scalzo (12155758), Daniela Fonseca de Freitas (13822730), Cecilia Casetta (12155764), Johnny Downs (4922650), Sophie E. Smart (13822733), Nikolaj Bak (3207450), James H. MacCabe (7955552), Hitesh Shetty (741747), Søren Rahn Christensen (12155770), Bruce J. Kinon (13822736), Aviv Segev (822223)   +17 more
core   +1 more source

Dynamics of Body Composition and Metabolic Risk in Adolescents With Obesity Under GLP‐1 Receptor Agonist Therapy

Acta Paediatrica, EarlyView.
ABSTRACT Aim To explore changes in body composition in adolescents with obesity treated with glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) and their association with metabolic syndrome (MetS) components. Methods This real‐world retrospective study included adolescents (12–18 years) with obesity who received multidisciplinary lifestyle‐based ...
Adar Lopez, Liat Perl, Eyal Cohen‐Sela, Ophir Borger, Yael Issan, Hagar Interator, Erez Azoulay, Hadar Moran‐Lev, Ronit Lubetzky, Shira Zelber‐Sagi, Yael Lebenthal, Avivit Brener   +11 more
wiley   +1 more source

Gold‐standard evidence and best practice guidance for menstrual cycle‐informed clinical care: An overview for clinicians

British Journal of Clinical Psychology, EarlyView.
Abstract Objectives To synthesize current evidence and provide clinically actionable recommendations for integrating menstrual cycle‐related processes—particularly hormone sensitivity, Premenstrual Dysphoric Disorder (PMDD) and Premenstrual Exacerbation (PME)—into psychological assessment, formulation and treatment.
Ellen R. Lambert, Louise N. Nolan, Katja M. Schmalenberger   +2 more
wiley   +1 more source